Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

Pharmaceutical

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals' headquarters in Cambridge, MA, United States

Yvonne Greenstreet

Brett Budzinski

Gabriel Robbie

John Gansner

Yutaka Okada

James Reindel

Bryan Supran

Tara Smith

Melissa Mclaughlin

Mike Tirozzi

Christine Lindenboom

Vasant Jadhav

Timothy Maines

Kevin Fitzgerald

Jeff Poulton

Tolga Tanguler

Pushkal Garg

Dennis A. Ausiello

Margaret A. Hamburg

Olivier Brandicourt

Elliott Sigal

Peter N. Kellogg

David E.i. Pyott

Colleen Reitan

Amy W. Schulman

The Leadership Team at Alnylam Pharmaceuticals is responsible for setting the strategic direction and operational oversight of the company, ensuring alignment with its mission to pioneer RNAi therapeutics. Comprising executives from various functional areas such as research, finance, human resources, and compliance, the team collaborates to drive innovation, manage risks, and enhance organizational performance, ultimately focused on delivering transformative medicines to patients.

Leadership Team

The Research and Development team at Alnylam Pharmaceuticals is dedicated to advancing the discovery and development of innovative RNAi therapeutics. This multidisciplinary team, comprising scientists, engineers, and managers, collaborates on various research initiatives, from early-stage discovery through process development and clinical research, to optimize therapeutic efficacy and safety. Their collective expertise drives the development pipeline, ensuring that cutting-edge RNAi medicines move from concept to market.

Research and Development

The Clinical Operations team at Alnylam Pharmaceuticals is essential for overseeing the planning, execution, and management of clinical trials for RNAi therapeutics. This team collaborates closely on trial design, data management, and regulatory compliance to ensure the effectiveness and safety of innovative treatments. Their comprehensive expertise supports the company's mission to develop groundbreaking medicines, while optimizing operational efficiency and maintaining high standards in clinical research.

Clinical Operations

The Finance and Accounting team at Alnylam Pharmaceuticals plays a crucial role in managing the company's financial health and strategic planning. This team is responsible for financial forecasting, budgeting, and reporting, ensuring compliance with accounting standards, and conducting internal audits. Additionally, they support business operations through financial analysis and resource allocation to facilitate decision-making for the successful development and commercialization of RNAi therapeutics.

Finance and Accounting

The Human Resources and Talent Management team at Alnylam Pharmaceuticals is dedicated to attracting, developing, and retaining top talent to support the company’s mission in RNAi therapeutics. This team ensures effective HR practices across various functions, from talent acquisition and training to employee engagement and HR analytics, fostering a diverse and high-performing workforce that drives innovation and growth in the biopharmaceutical industry.

Human Resources and Talent Management

The Data Analytics and Engineering team at Alnylam Pharmaceuticals focuses on leveraging data-driven insights to enhance the development and delivery of RNAi therapeutics. This team is responsible for the design and implementation of advanced analytics solutions, ensuring data integrity and security, optimizing operational processes, and supporting international partnerships through innovative data strategies. By combining expertise in IT, software engineering, and process validation, they aim to drive efficiencies and support the company's mission of transforming patient care.

Data Analytics and Engineering

Alnylam Pharmaceuticals

Org chart

Board & advisors

Teams